1. Home
  2. RENE vs ATAI Comparison

RENE vs ATAI Comparison

Compare RENE & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENE
  • ATAI
  • Stock Information
  • Founded
  • RENE 2021
  • ATAI 2018
  • Country
  • RENE United States
  • ATAI Germany
  • Employees
  • RENE N/A
  • ATAI N/A
  • Industry
  • RENE Blank Checks
  • ATAI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RENE Finance
  • ATAI Health Care
  • Exchange
  • RENE Nasdaq
  • ATAI Nasdaq
  • Market Cap
  • RENE 248.9M
  • ATAI 214.8M
  • IPO Year
  • RENE 2022
  • ATAI 2021
  • Fundamental
  • Price
  • RENE $11.62
  • ATAI $1.52
  • Analyst Decision
  • RENE
  • ATAI Strong Buy
  • Analyst Count
  • RENE 0
  • ATAI 4
  • Target Price
  • RENE N/A
  • ATAI $9.00
  • AVG Volume (30 Days)
  • RENE 218.7K
  • ATAI 2.2M
  • Earning Date
  • RENE 01-01-0001
  • ATAI 11-13-2024
  • Dividend Yield
  • RENE N/A
  • ATAI N/A
  • EPS Growth
  • RENE 42.92
  • ATAI N/A
  • EPS
  • RENE 0.43
  • ATAI N/A
  • Revenue
  • RENE N/A
  • ATAI $331,000.00
  • Revenue This Year
  • RENE N/A
  • ATAI $44.72
  • Revenue Next Year
  • RENE N/A
  • ATAI N/A
  • P/E Ratio
  • RENE $26.81
  • ATAI N/A
  • Revenue Growth
  • RENE N/A
  • ATAI N/A
  • 52 Week Low
  • RENE $10.88
  • ATAI $1.03
  • 52 Week High
  • RENE $11.67
  • ATAI $2.85
  • Technical
  • Relative Strength Index (RSI)
  • RENE 59.82
  • ATAI 57.65
  • Support Level
  • RENE $11.62
  • ATAI $1.53
  • Resistance Level
  • RENE $11.67
  • ATAI $1.95
  • Average True Range (ATR)
  • RENE 0.01
  • ATAI 0.20
  • MACD
  • RENE -0.00
  • ATAI 0.03
  • Stochastic Oscillator
  • RENE 70.59
  • ATAI 52.22

About RENE Cartesian Growth Corporation II

Cartesian Growth Corp II is a blank check company.

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Share on Social Networks: